182 related articles for article (PubMed ID: 31571573)
21. The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes.
De Marco G; Helliwell P; McGonagle D; Emery P; Coates LC; Hensor EMA; Marzo-Ortega H
BMC Musculoskelet Disord; 2017 Jul; 18(1):303. PubMed ID: 28720139
[TBL] [Abstract][Full Text] [Related]
22. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.
Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Koldingsnes W; Mowinckel P; Kvien TK
Ann Rheum Dis; 2007 Aug; 66(8):1038-42. PubMed ID: 17213251
[TBL] [Abstract][Full Text] [Related]
23. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
24. The actual role of therapy with traditional disease-modifying antirheumatic drugs in psoriatic arthritis.
Soriano ER
J Rheumatol Suppl; 2012 Jul; 89():67-70. PubMed ID: 22751597
[TBL] [Abstract][Full Text] [Related]
25. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
[TBL] [Abstract][Full Text] [Related]
26. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
Spadaro A; Riccieri V; Sili-Scavalli A; Sensi F; Taccari E; Zoppini A
Clin Exp Rheumatol; 1995; 13(5):589-93. PubMed ID: 8575136
[TBL] [Abstract][Full Text] [Related]
27. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
Salvarani C; Cantini F; Olivieri I
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
29. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Mary J; De Bandt M; Lukas C; Morel J; Combe B
J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
Kristensen LE; Gülfe A; Saxne T; Geborek P
Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
[TBL] [Abstract][Full Text] [Related]
31. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.
Kingsley GH; Kowalczyk A; Taylor H; Ibrahim F; Packham JC; McHugh NJ; Mulherin DM; Kitas GD; Chakravarty K; Tom BD; O'Keeffe AG; Maddison PJ; Scott DL
Rheumatology (Oxford); 2012 Aug; 51(8):1368-77. PubMed ID: 22344575
[TBL] [Abstract][Full Text] [Related]
32. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
[TBL] [Abstract][Full Text] [Related]
33. Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?
Ye W; Coates LC
Rheum Dis Clin North Am; 2019 Aug; 45(3):325-339. PubMed ID: 31277747
[TBL] [Abstract][Full Text] [Related]
34. Therapy with cyclosporine in psoriatic arthritis.
Olivieri I; Salvarani C; Cantini F; Macchioni L; Padula A; Niccoli L; Boiardi L; Portioli I
Semin Arthritis Rheum; 1997 Aug; 27(1):36-43. PubMed ID: 9287388
[TBL] [Abstract][Full Text] [Related]
35. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study.
Mease PJ; Gladman DD; Keystone EC;
Arthritis Rheum; 2006 May; 54(5):1638-45. PubMed ID: 16646026
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate in psoriatic arthritis.
Mease P
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S41-5. PubMed ID: 24219040
[TBL] [Abstract][Full Text] [Related]
37. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis.
Sheane BJ; Thavaneswaran A; Gladman DD; Chandran V
J Rheumatol; 2016 Sep; 43(9):1718-23. PubMed ID: 27422895
[TBL] [Abstract][Full Text] [Related]
38. Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.
Marchesoni A; Lubrano E; Cauli A; Ricci M; Manara M
J Rheumatol Suppl; 2015 Nov; 93():61-4. PubMed ID: 26523060
[TBL] [Abstract][Full Text] [Related]
39. Role of Methotrexate in the Management of Psoriatic Arthritis.
Elmamoun M; Chandran V
Drugs; 2018 Apr; 78(6):611-619. PubMed ID: 29616495
[TBL] [Abstract][Full Text] [Related]
40. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.
Gladman DD; Mease PJ; Ritchlin CT; Choy EH; Sharp JT; Ory PA; Perdok RJ; Sasso EH
Arthritis Rheum; 2007 Feb; 56(2):476-88. PubMed ID: 17265483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
